Patient
SITE010-0181
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE010 (ESP) (Dr. Silva)
consented 2026-03-31
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
mild
assessed
2026-09-03
Grade 1 Fatigue — outcome: RECOVERED/RESOLVED; onset 2023-02-27 (study day 139); relationship: NOT RELATED
mild
assessed
2026-06-05
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-11-29 (study day 49); relationship: NOT RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.